EPISODE · Jul 1, 2026 · 6 MIN
DESTINY-Breast11 and Surrogate Endpoints
from PharmOncology · host Ming-Hei Tai
Thoughts on using pCR as a surrogate endpointDESTINY-Breast11: https://pubmed.ncbi.nlm.nih.gov/41130363/Clinical Cancer Research publication on pCR, EFS and OS: https://aacrjournals.org/clincancerres/article/26/12/2838/82378/Pathologic-Complete-Response-after-NeoadjuvantBMJ publication on pCR, EFS and OS: https://www.bmj.com/content/375/bmj-2021-066381FDA-sponsored analysis: https://pubmed.ncbi.nlm.nih.gov/24529560/KATHERINE trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1814017
What this episode covers
Thoughts on using pCR as a surrogate endpointDESTINY-Breast11: https://pubmed.ncbi.nlm.nih.gov/41130363/Clinical Cancer Research publication on pCR, EFS and OS: https://aacrjournals.org/clincancerres/article/26/12/2838/82378/Pathologic-Complete-Response-after-NeoadjuvantBMJ publication on pCR, EFS and OS: https://www.bmj.com/content/375/bmj-2021-066381FDA-sponsored analysis: https://pubmed.ncbi.nlm.nih.gov/24529560/KATHERINE trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1814017
NOW PLAYING
DESTINY-Breast11 and Surrogate Endpoints
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.